Macquarie Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-116,807
Closed -$4.02M 1654
2014
Q4
$4.02M Sell
116,807
-76,184
-39% -$2.48M 0.01% 783
2014
Q3
$5.76M Sell
192,991
-114,179
-37% -$2.42M 0.01% 671
2014
Q2
$6.16M Buy
307,170
+19,730
+7% +$453K 0.01% 645
2014
Q1
$7.81M Buy
287,440
+149,210
+108% +$3.96M 0.01% 558
2013
Q4
$2.87M Buy
138,230
+39,724
+40% +$749K 0.01% 831
2013
Q3
$1.79M Sell
98,506
-3,715
-4% -$67.1K ﹤0.01% 987
2013
Q2
$1.7M Buy
+102,221
New +$1.63M ﹤0.01% 974

Other funds holding AUXL

Macquarie Group's AUXL Position: Q1 2015 in Review

Macquarie Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 116,807 shares — an estimated $4.02M sold.

Macquarie Group first reported a position in AUXL in Q2 2013 and held it in 7 quarters. The position peaked at $7.81M in Q1 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Macquarie Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Macquarie Group sold 116,807 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $4.02M.
  • Macquarie Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Macquarie Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $7.81M in Q1 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Macquarie Group's 13F filing for Q1 2015, filed 18 May 2015.